DOUGLAS G BAILEY

CIK 1246268 · Executive Chairman · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.81M

Companies

2

Total Filings

66

Lifetime Open-Market Net

-$1.56M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
FTEK Director 2,093,561 $1.34 $2.81M -$1.98M 61 2026-06-05
ENDOCYTE INC (ECYT) Delisted Director 475,363 $420.0K 5 2012-06-04

Recent Filings · Page 5 of 7

66 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2012-03-13 FTEK Grant (A) $0 EDGAR
2011-12-16 ENDOCYTE INC (ECYT) Delisted Buy (P) +125,000 $420.0K EDGAR
2011-05-31 ENDOCYTE INC (ECYT) Delisted Grant (A) $0 EDGAR
2011-05-23 FTEK Mixed +30,000 $140.6K EDGAR
2011-03-09 ENDOCYTE INC (ECYT) Delisted Mixed +389,362 $0 EDGAR
2011-02-11 ENDOCYTE INC (ECYT) Delisted Mixed +1,254,660 $0 EDGAR
2010-12-22 FTEK Grant (A) $0 EDGAR
2010-06-03 FTEK Buy (P) +15,000 $83.5K EDGAR
2009-06-30 FTEK Sell (S) −20,347 -$198.3K EDGAR
2009-05-27 FTEK Grant (A) $0 EDGAR
Showing 4150 of 66
Page 5 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.